Article Details
Retrieved on: 2025-05-13 13:41:48
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Obicetrapib, a CETP inhibitor, and its efficacy in lowering LDL cholesterol in patients with familial hypercholesterolemia or atherosclerosis. Diabetes is highlighted as a notable adverse event; this relates to managing lipid disorders, statin use, and cardiovascular risks.
Article found on: www.healio.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here